Skip to main content
TipRanks
Go Ultimate75% OFF

Compare Crispr Therapeutics AG (CRSP) vs. Competitors

11,101 Followers

Comparison Results

Comparison results
NamePriceMarket CapP/E RatioYearly GainAnalyst ConsensusAnalyst Price TargetCompareTop Analysts' Price TargetSmart ScoreFollow
CRSPCrispr Therapeutics AG$39.10$3.79B-8.25-20.67%Moderate BuyUnlock the CRSP analyst price target with TipRanks PremiumCRSPUnlock the CRSP top-analyst price target with TipRanks Premium
NTLAIntellia Therapeutics$10.00$1.40B-2.9824.38%HoldUnlock the NTLA analyst price target with TipRanks PremiumCRSP vs NTLAUnlock the NTLA top-analyst price target with TipRanks Premium
BEAMBeam Therapeutics$20.90$2.16B-20.901.46%Strong BuyUnlock the BEAM analyst price target with TipRanks PremiumCRSP vs BEAMUnlock the BEAM top-analyst price target with TipRanks Premium
LEGNLegend Biotech$15.25$2.96B-1525.00-44.61%Moderate BuyUnlock the LEGN analyst price target with TipRanks PremiumCRSP vs LEGNUnlock the LEGN top-analyst price target with TipRanks Premium
KYMRKymera Therapeutics$115.31$9.84B-31.7778.42%Strong BuyUnlock the KYMR analyst price target with TipRanks PremiumCRSP vs KYMRUnlock the KYMR top-analyst price target with TipRanks Premium

Performance Comparison

-50%0%50%100%150%Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
Performance comparison by fund
TickerCompany NamePriceChange% Change
CRSPCrispr Therapeutics AG39.10-12.15-23.71%
NTLAIntellia Therapeutics10.001.6519.76%
BEAMBeam Therapeutics20.90-2.72-11.52%
LEGNLegend Biotech15.25-11.90-43.83%
KYMRKymera Therapeutics115.3149.7275.80%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts